How Lilly is joining Novo in the crusade to circumvent Medicare's block on weight loss drugs
The leaders in the business of weight-loss drugs, Novo Nordisk and Eli Lilly, are fighting on a number of fronts to get Medicare officials to pay for the popular medicines.
Yahoo Finance
7 days ago